Found 81 clinical trials
A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
This study includes a dose escalation part(phase I) and a dose extension part(phase II).
- 51 views
- 01 Apr, 2021
- 1 location
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
Multi-center, randomized, double-blind, vehicle-controlled, parallel group, multi-dose escalation study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).
- 0 views
- 17 May, 2022
- 2 locations
Cold Plasma to Treat Hair Loss
Self applied cold plasma activated medium used for androgenetic alopecia
- 1272 views
- 23 Apr, 2022
- 1 location
Low Level Light Therapy (LLLT) for Hair Growth
A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.
- 1173 views
- 07 Feb, 2022
- 1 location
A Study to Evaluate the Efficacy and Safety of AD-208
The purpose of this study is to evaluate the efficacy and safety of AD-208.
- 0 views
- 23 Nov, 2021
- 1 location
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)
Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata
- 0 views
- 09 May, 2022
- 1 location
Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair
The objective of this study is to assess the effectiveness and safety of a novel dietary supplement containing botanical ingredients for hair thinning in men over the course of six months of
- 0 views
- 06 May, 2022
- 1 location
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
> Hypothesis: KGF-HS will result in less than 50% hair loss by the end of 4 cycles of chemotherapy. The investigators will evaluate hair loss using the CTCAE (Common Terminology Criteria for Adverse Events
- 34 views
- 18 Dec, 2021
- 1 location
Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients
Prevention System to prevent chemotherapy-induced alopecia. This project seeks to demonstrate that the Orbis Paxman Hair Loss Prevention System is safe and effective in reducing chemotherapy-induced
- 0 views
- 14 May, 2022
- 1 location
PBMT for the Management of CIA ( HAIRLASER )
-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive
- 0 views
- 08 Apr, 2022
- 1 location